BIOMAT Database Logo BIOMAT Database Logo

[Biochemical bone markers and biological effects of osteoporosis therapy]. 2012

Branka Kovacev-Zavisić, and Jovanka Novaković-Paro, and Nikola Curić, and Tijana Icin, and Ljiljana Todorović-Djilas, and Nemanja Kovacev
Klinika za endokrinologiju, dijabetes i bolesti metabolizma KC Vojvodine, Novi Sad, Srbija. brankakovacevzavisic@gmail.com

UI MeSH Term Description Entries
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015663 Osteoporosis, Postmenopausal Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency. Bone Loss, Perimenopausal,Bone Loss, Postmenopausal,Perimenopausal Bone Loss,Postmenopausal Bone Loss,Postmenopausal Osteoporosis,Osteoporosis, Post-Menopausal,Bone Losses, Perimenopausal,Bone Losses, Postmenopausal,Osteoporoses, Post-Menopausal,Osteoporoses, Postmenopausal,Osteoporosis, Post Menopausal,Perimenopausal Bone Losses,Post-Menopausal Osteoporoses,Post-Menopausal Osteoporosis,Postmenopausal Bone Losses,Postmenopausal Osteoporoses
D015914 Estrogen Replacement Therapy The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy. Hormone Replacement Therapy, Post-Menopausal,Postmenopausal Hormone Replacement Therapy,Replacement Therapy, Estrogen,Estrogen Progestin Combination Therapy,Estrogen Progestin Replacement Therapy,Estrogen Replacement,Replacement, Estrogen,Therapy, Estrogen Replacement,Estrogen Replacement Therapies,Estrogen Replacements,Hormone Replacement Therapy, Post Menopausal,Replacement Therapies, Estrogen,Replacements, Estrogen,Therapies, Estrogen Replacement
D058866 Osteoporotic Fractures Breaks in bones resulting from low bone mass and microarchitectural deterioration characteristic of OSTEOPOROSIS. Fracture, Osteoporotic,Fractures, Osteoporotic,Osteoporotic Fracture

Related Publications

Branka Kovacev-Zavisić, and Jovanka Novaković-Paro, and Nikola Curić, and Tijana Icin, and Ljiljana Todorović-Djilas, and Nemanja Kovacev
[Biochemical markers for bone activity and osteoporosis].
January 1995, Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques,
Branka Kovacev-Zavisić, and Jovanka Novaković-Paro, and Nikola Curić, and Tijana Icin, and Ljiljana Todorović-Djilas, and Nemanja Kovacev
Bone markers and osteoporosis therapy.
July 2014, Arquivos brasileiros de endocrinologia e metabologia,
Branka Kovacev-Zavisić, and Jovanka Novaković-Paro, and Nikola Curić, and Tijana Icin, and Ljiljana Todorović-Djilas, and Nemanja Kovacev
Biochemical markers of bone turnover in osteoporosis.
June 1997, Revue du rhumatisme (English ed.),
Branka Kovacev-Zavisić, and Jovanka Novaković-Paro, and Nikola Curić, and Tijana Icin, and Ljiljana Todorović-Djilas, and Nemanja Kovacev
Biochemical markers of bone turnover in osteoporosis.
August 1997, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,
Branka Kovacev-Zavisić, and Jovanka Novaković-Paro, and Nikola Curić, and Tijana Icin, and Ljiljana Todorović-Djilas, and Nemanja Kovacev
[Biochemical markers of bone formation in osteoporosis].
May 1996, Rinsho byori. The Japanese journal of clinical pathology,
Branka Kovacev-Zavisić, and Jovanka Novaković-Paro, and Nikola Curić, and Tijana Icin, and Ljiljana Todorović-Djilas, and Nemanja Kovacev
Biological variation of biochemical bone markers.
January 1994, Scandinavian journal of clinical and laboratory investigation. Supplementum,
Branka Kovacev-Zavisić, and Jovanka Novaković-Paro, and Nikola Curić, and Tijana Icin, and Ljiljana Todorović-Djilas, and Nemanja Kovacev
Biochemical markers of bone turnover. Applications for osteoporosis.
June 1998, Endocrinology and metabolism clinics of North America,
Branka Kovacev-Zavisić, and Jovanka Novaković-Paro, and Nikola Curić, and Tijana Icin, and Ljiljana Todorović-Djilas, and Nemanja Kovacev
[Biochemical markers for bone metabolism in severe osteoporosis].
December 2001, Clinical calcium,
Branka Kovacev-Zavisić, and Jovanka Novaković-Paro, and Nikola Curić, and Tijana Icin, and Ljiljana Todorović-Djilas, and Nemanja Kovacev
[Biochemical markers of bone turnover for treatment of osteoporosis].
March 2002, Nihon rinsho. Japanese journal of clinical medicine,
Branka Kovacev-Zavisić, and Jovanka Novaković-Paro, and Nikola Curić, and Tijana Icin, and Ljiljana Todorović-Djilas, and Nemanja Kovacev
[Biochemical markers of bone remodeling in assessment of osteoporosis].
October 1997, Casopis lekaru ceskych,
Copied contents to your clipboard!